190 related articles for article (PubMed ID: 31518962)
21. New bis(hydroxymethyl) alkanoate curcuminoid derivatives exhibit activity against triple-negative breast cancer in vitro and in vivo.
Hsieh MT; Chang LC; Hung HY; Lin HY; Shih MH; Tsai CH; Kuo SC; Lee KH
Eur J Med Chem; 2017 May; 131():141-151. PubMed ID: 28319780
[TBL] [Abstract][Full Text] [Related]
22. H-Ferritin Enriches the Curcumin Uptake and Improves the Therapeutic Efficacy in Triple Negative Breast Cancer Cells.
Pandolfi L; Bellini M; Vanna R; Morasso C; Zago A; Carcano S; Avvakumova S; Bertolini JA; Rizzuto MA; Colombo M; Prosperi D
Biomacromolecules; 2017 Oct; 18(10):3318-3330. PubMed ID: 28886247
[TBL] [Abstract][Full Text] [Related]
23. Potential Role of Curcumin and Its Nanoformulations to Treat Various Types of Cancers.
Kabir MT; Rahman MH; Akter R; Behl T; Kaushik D; Mittal V; Pandey P; Akhtar MF; Saleem A; Albadrani GM; Kamel M; Khalifa SAM; El-Seedi HR; Abdel-Daim MM
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33800000
[TBL] [Abstract][Full Text] [Related]
24. Milk-Derived Exosomes as Nanocarriers to Deliver Curcumin and Resveratrol in Breast Tissue and Enhance Their Anticancer Activity.
González-Sarrías A; Iglesias-Aguirre CE; Cortés-Martín A; Vallejo F; Cattivelli A; Del Pozo-Acebo L; Del Saz A; López de Las Hazas MC; Dávalos A; Espín JC
Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270004
[TBL] [Abstract][Full Text] [Related]
25. Synergistic antitumor effect of NVP-BEZ235 and CAPE on MDA-MB-231 breast cancer cells.
Torki S; Soltani A; Shirzad H; Esmaeil N; Ghatrehsamani M
Biomed Pharmacother; 2017 Aug; 92():39-45. PubMed ID: 28528184
[TBL] [Abstract][Full Text] [Related]
26. Apoptotic Resistance of Metastatic Tumor Cells in Triple Negative Breast Cancer: Roles of Death Receptor-5.
Kamalabadi-Farahani M; H Najafabadi MR; Jabbarpour Z
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1743-1748. PubMed ID: 31244295
[TBL] [Abstract][Full Text] [Related]
27. A combination index and glycoproteomics-based approach revealed synergistic anticancer effects of curcuminoids of turmeric against prostate cancer PC3 cells.
Wei MM; Zhao SJ; Dong XM; Wang YJ; Fang C; Wu P; Song GQ; Gao JN; Huang ZH; Xie T; Zhou JL
J Ethnopharmacol; 2021 Mar; 267():113467. PubMed ID: 33058923
[TBL] [Abstract][Full Text] [Related]
28. Apoptotic Effect of Gemini Curcumin on MDA-MB-468 Breast Cancer Cell Line.
Hajizadeh M; Ghoran SH; Azeez HJ; Feizi MAH; Babaei E
Anticancer Agents Med Chem; 2022; 22(11):2181-2188. PubMed ID: 34773965
[TBL] [Abstract][Full Text] [Related]
29. Enhanced Antiproliferation Potency of Electrical Pulse-Mediated Metformin and Cisplatin Combination Therapy on MDA-MB-231 Cells.
Sahu P; Camarillo IG; Sundararajan R
Appl Biochem Biotechnol; 2022 Jan; 194(1):18-36. PubMed ID: 34741262
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, characterization and anti-cancer activity of Pluronic F68-curcumin conjugate micelles.
Cai Y; Sun Z; Fang X; Fang X; Xiao F; Wang Y; Chen M
Drug Deliv; 2016 Sep; 23(7):2587-2595. PubMed ID: 26066393
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive proteomics and sialiomics of the anti-proliferative activity of safranal on triple negative MDA-MB-231 breast cancer cell lines.
Zarrineh M; Ashrafian S; Jensen P; Nawrocki A; Ansari AM; Rezadoost H; Ghassempour A; Larsen MR
J Proteomics; 2022 May; 259():104539. PubMed ID: 35240313
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effects of curcumin on gastric cancer cells: a proteomic study of molecular targets.
Cai XZ; Huang WY; Qiao Y; Du SY; Chen Y; Chen D; Yu S; Che RC; Liu N; Jiang Y
Phytomedicine; 2013 Apr; 20(6):495-505. PubMed ID: 23351961
[TBL] [Abstract][Full Text] [Related]
33. Demethoxycurcumin inhibits energy metabolic and oncogenic signaling pathways through AMPK activation in triple-negative breast cancer cells.
Shieh JM; Chen YC; Lin YC; Lin JN; Chen WC; Chen YY; Ho CT; Way TD
J Agric Food Chem; 2013 Jul; 61(26):6366-75. PubMed ID: 23777448
[TBL] [Abstract][Full Text] [Related]
34. Estrogen receptor-α36 is involved in icaritin induced growth inhibition of triple-negative breast cancer cells.
Wang X; Zheng N; Dong J; Wang X; Liu L; Huang J
J Steroid Biochem Mol Biol; 2017 Jul; 171():318-327. PubMed ID: 28529129
[TBL] [Abstract][Full Text] [Related]
35. Curcumin Delivery by Poly(Lactide)-Based Co-Polymeric Micelles: An In Vitro Anticancer Study.
Kumari P; Swami MO; Nadipalli SK; Myneni S; Ghosh B; Biswas S
Pharm Res; 2016 Apr; 33(4):826-41. PubMed ID: 26597940
[TBL] [Abstract][Full Text] [Related]
36. Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice.
Masuelli L; Benvenuto M; Fantini M; Marzocchella L; Sacchetti P; Di Stefano E; Tresoldi I; Izzi V; Bernardini R; Palumbo C; Mattei M; Lista F; Galvano F; Modesti A; Bei R
J Biol Regul Homeost Agents; 2013; 27(1):105-19. PubMed ID: 23489691
[TBL] [Abstract][Full Text] [Related]
37. Orthogonal self-assembly of an organoplatinum(II) metallacycle and cucurbit[8]uril that delivers curcumin to cancer cells.
Datta S; Misra SK; Saha ML; Lahiri N; Louie J; Pan D; Stang PJ
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8087-8092. PubMed ID: 30038010
[TBL] [Abstract][Full Text] [Related]
38. Curcumin suppresses 4-hydroxytamoxifen resistance in breast cancer cells by targeting SLUG/Hexokinase 2 pathway.
Geng C; Li J; Ding F; Wu G; Yang Q; Sun Y; Zhang Z; Dong T; Tian X
Biochem Biophys Res Commun; 2016 Apr; 473(1):147-153. PubMed ID: 27012210
[TBL] [Abstract][Full Text] [Related]
39. Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFkappaB, cyclinD and MMP-1 transcription.
Liu Q; Loo WT; Sze SC; Tong Y
Phytomedicine; 2009 Oct; 16(10):916-22. PubMed ID: 19524420
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of the Warburg effect with a natural compound reveals a novel measurement for determining the metastatic potential of breast cancers.
Arora R; Schmitt D; Karanam B; Tan M; Yates C; Dean-Colomb W
Oncotarget; 2015 Jan; 6(2):662-78. PubMed ID: 25575825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]